Details

Autor(en) / Beteiligte

• Taguchi, Tomomi
• Kimura, Kaori
• Suzuki, Agena
• Fujishima, Rei
• Shimizu, Naoya
• Hoshiyama, Ayako
• Masaki, Tsuguto
• Inoue, Mitsuko
• Kato, Yukiko
• Satomi, Takebe
• Takano, Koji
• Imada, Tasuku
• Sasaki, Shugo
• Miyatsuka, Takeshi

Titel

ATP6AP2 is robustly expressed in pancreatic β cells and neuroendocrine tumors, and plays a role in maintaining cellular viability

Ist Teil von

• Scientific reports, 2023-06, Vol.13 (1), p.9260-9260, Article 9260

Ort / Verlag

London: Nature Publishing Group UK

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• ATP6AP2, also known as (pro)renin receptor, has been shown to be expressed in several tissues including pancreatic β cells. Whereas ATP6AP2 plays an important role in regulating insulin secretion in mouse pancreatic β cells, the expression profiles and roles of ATP6AP2 in human pancreatic endocrine cells and neuroendocrine tumor cells remain unclear. Here in this study, we investigated the expression profiles of ATP6AP2 in pancreatic endocrine cells, and found that ATP6AP2 is robustly expressed in pancreatic insulinoma cells as well as in normal β cells. Although ATP6AP2 was also expressed in low-grade neuroendocrine tumors, it was not or faintly detected in intermediate- and high-grade neuroendocrine tumors. Knockdown experiments of the Atp6ap2 gene in rat insulinoma-derived INS-1 cells demonstrated decreased cell viability accompanied by a significant increase in apoptotic cells. Taken together, these findings suggest that ATP6AP2 plays a role in maintaining cellular homeostasis in insulinoma cells, which could lead to possible therapeutic approaches for endocrine tumors.